Mercy Medical Center Completes Beta Studies for Integrated Hematology and Automated Diabetes Testing Solution

Share Name	Share Symbol	Market	Type
Biotest AG	TG:BIO	Tradegate	Ordinary Share

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	0.00	0.00%	41.60	41.00	42.00				0.00	20:58:00

Biotest (TG:BIO)
Historical Stock Chart

From May 2019 to May 2024

MUNDELEIN, Ill., April 22 /PRNewswire/ -- Sysmex America, Inc. today announced the successful completion of Mercy Medical Center's (Canton, OH) beta studies for its integrated hematology and A1C automation solution. This first-of-kind solution, which combines the Sysmex HST-N hematology automation platform and the Bio-Rad Laboratories, Inc. VARIANT(TM) II TURBO Link, enables on-demand, automated diabetes testing in a random access setting. "This integrated testing solution, now fully on-line at Mercy, also utilizes automated decision logic rules software, Sysmex MOLIS WAM(TM), to maximize efficiencies in the area of data and sample management and labor utilization," said Barbara Carter, Coordinator Automated/Core Laboratory, Mercy Medical Center. Mercy Medical Center's early adoption of the integrated hematology and A1C Testing Solution aligns with the hospital's impressive list of world, national, state and Stark county's "firsts." The hospital is jointly owned and operated by the Sisters of Charity Health System and University Hospitals Health System. This integrated testing Solution will be available to hospitals across the nation beginning the end of April 2008. "As an early adopter of the automated A1C Testing Solution, we are providing superior diabetes testing services that positively impact the quality and timeliness of the acute care and management of diabetic patients. With diabetes affecting over 20 million children and adults in the United States, coupled with the nation's obesity epidemic, we saw the need to create a laboratory infrastructure for the future," said Mary Ann Burich-Boccia, Administrative Director, Laboratory, Mercy Medical Center. "By automating and consolidating our high volume hematology and diabetes testing, we have dramatically improved our operational efficiency while reducing costs and errors. And, with seventy-five percent of our samples no longer needing technologist-touch, we are freeing our technologists for more critical tasks such as abnormal patient result review," she added. Mercy Medical Center's integrated testing solution includes the Sysmex HST-302 automated platform -- two XE-Series automated hematology analyzers, one SP-1000i automated slide maker and stainer, MOLIS WAM, one TS-500 Tube Sorter/archiver, Return Line and the Bio-Rad VARIANT II TURBO Link A1C testing system. "Our A1C method uses HPLC technology, the industry's gold standard for A1C testing. In addition to diabetes monitoring, our method detects some common hemoglobin abnormalities. This clinical information can be forwarded to the physician, adding valuable patient information," said Scott Joksch, Senior Product Manager at Bio-Rad. "In addition to enhancing its diabetic testing services, Mercy Medical Center's foresight has enabled the automation of testing and data management of 90% of tests performed on EDTA samples and automated sample management of virtually 100% of all EDTA samples (i.e. CBC, Diff, Retic, ESR and other esoteric tests)," said Nilam Patel, Sr. Product Manager, Automation Solutions, Sysmex America, Inc. "This Lavender Top Management(TM) solution by Sysmex offers clinical laboratories quality results, superior instrument and automation performance (uptime) and improved productivity, turn around times and labor utilization," added Patel. About HbA1c The hemoglobin A1c (A1C) blood test, which measures the amount of glucose attached to the hemoglobin in the red blood cell, is an estimate of a patient's blood glucose control during the previous three to four months. Diabetes is a chronic condition that can increase a patient's risk for developing serious complications including heart disease and stroke, high blood pressure, blindness, kidney and nervous system diseases. Proper diabetes management can delay or even prevent the onset of complications, allowing patients to live healthier, more productive lives. About Mercy Medical Center Mercy Medical Center, a nonprofit corporation of the Sisters of Charity Health System and University Hospitals Health System, operates a 476-bed hospital serving Stark, Carroll, Wayne, Holmes and Tuscarawas Counties and parts of Southeastern Ohio. It has 550 physicians on its Medical Staff and employs 2,500 people. Mercy operates outpatient health centers in Carrollton, Jackson Township, Lake Township, Louisville and North Canton. A Catholic hospital, Mercy Medical Center, upholds the mission and philosophy of the Sisters of Charity of St. Augustine and continues to be responsive to the needs of the community, including the provision of care to all, regardless of their ability to pay. For more information, see http://www.cantonmercy.com/. About Bio-Rad Bio-Rad Laboratories, Inc. (Amex: BIO; BIOb) has remained at the center of scientific discovery for more than 50 years manufacturing and distributing a broad range of products for the life science research and clinical diagnostic markets. The company is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 85,000 research and industry customers worldwide through its global network of operations. The company employs approximately 6,300 people globally and had revenues approaching $1.5 billion in 2007. For more information, visit http://www.bio-rad.com/. About Sysmex America, Inc. Sysmex America, Inc., the U.S. headquarters of Sysmex Corporation (Kobe, Japan), is a world leader in clinical laboratory systemization and solutions, including clinical diagnostics, automation and information systems. Serving customers for over 40 years, Sysmex focuses on extending the boundaries of diagnostic science while providing the management information tools that make a real difference in clinical and operational results for people worldwide. For more information about Sysmex, please visit http://www.sysmex.com/usa. DATASOURCE: Sysmex America, Inc. CONTACT: Tonua Fedusenko of TJS Communications, Inc., +1-570-384-0450, cell, +1-302-893-3948, , for Sysmex America, Inc. Web site: http://www.sysmex.com/usa http://www.bio-rad.com/ http://www.cantonmercy.com/

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

BIO Biotest AG